Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Sintilimab + Anlotinib + Chemotherapy

1 clinical trial

1 indication

Indication
Sintilimab and Anlotinib in Combination With Chemotherapy
Clinical trial
A Prospective Single-center, Single-arm, Open-label Study of Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer
Status: Completed, Estimated PCD: 2022-04-01